6D71 Mild neurocognitive disorder International Classification of Diseases for Mortality and Morbidity Statistics, 11th Revision, v2026-01 Mild neurocognitive disorder is characterized by mild impairment in one or more cognitive domains relative to that expected given the individual’s age and general premorbid level of cognitive functioning, which represents a decline from the individual’s previous level of functioning. Diagnosis is based on report from the patient, informant, or clinical observation, and is accompanied by objective evidence of impairment by quantified clinical assessment or standardized cognitive testing. Cognitive impairment is not severe enough to significantly interfere with an individual’s ability to perform activities related to personal, family, social, educational, and/or occupational functioning or other important functional areas. Cognitive impairment is not attributable to normal aging and may be static, progressive, or may resolve or improve depending on underlying cause or treatment. Cognitive impairment may be attributable to an underlying acquired disease of the nervous system, a trauma, an infection or other disease process affecting the brain, use of specific substances or medications, nutritional deficiency or exposure to toxins, or the aetiology may be undetermined. The impairment is not due to current substance intoxication or withdrawal.
postcoordination Add Stem and/or Extension codes to form a cluster code which adds detail to the condition.
Has causing condition - a selection is required - multiple selections are allowed [select] 1C60 Human immunodeficiency virus disease associated with tuberculosis 1C61 Human immunodeficiency virus disease associated with malaria 1C62 Human immunodeficiency virus disease without mention of tuberculosis or malaria 1C60.0 HIV disease clinical stage 1 associated with tuberculosis 1C60.1 HIV disease clinical stage 2 associated with tuberculosis 1C60.2 HIV disease clinical stage 3 associated with tuberculosis 1C60.3 HIV disease clinical stage 4 associated with tuberculosis 1C60.Z Human immunodeficiency virus disease associated with tuberculosis, clinical stage unspecified 1C61.0 HIV disease clinical stage 1 associated with malaria 1C61.1 HIV disease clinical stage 2 associated with malaria 1C61.2 HIV disease clinical stage 3 associated with malaria 1C61.3 HIV disease clinical stage 4 associated with malaria 1C61.Z Human immunodeficiency virus disease associated with malaria, clinical stage unspecified 1C62.0 HIV disease clinical stage 1 without mention of tuberculosis or malaria 1C62.1 HIV disease clinical stage 2 without mention of tuberculosis or malaria 1C62.2 HIV disease clinical stage 3 without mention of tuberculosis or malaria 1C62.3 HIV disease clinical stage 4 without mention of tuberculosis or malaria 1C62.Z Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified 1C60.30 Kaposi sarcoma associated with human immunodeficiency virus disease associated with tuberculosis 1C60.3Y Other specified HIV disease clinical stage 4 associated with tuberculosis 1C60.3Z HIV disease clinical stage 4 associated with tuberculosis, unspecified 1C61.30 Kaposi sarcoma associated with human immunodeficiency virus disease associated with malaria 1C61.3Y Other specified HIV disease clinical stage 4 associated with malaria 1C61.3Z HIV disease clinical stage 4 associated with malaria, unspecified 1C62.30 Kaposi sarcoma associated with human immunodeficiency virus disease without mention of tuberculosis or malaria 1C62.3Y Other specified HIV disease clinical stage 4 without mention of tuberculosis or malaria 1C62.3Z HIV disease clinical stage 4 without mention of tuberculosis or malaria, unspecified 6C40 Disorders due to use of alcohol 6C41 Disorders due to use of cannabis 6C42 Disorders due to use of synthetic cannabinoids 6C43 Disorders due to use of opioids 6C44 Disorders due to use of sedatives, hypnotics or anxiolytics 6C45 Disorders due to use of cocaine 6C46 Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone 6C47 Disorders due to use of synthetic cathinones 6C48 Disorders due to use of caffeine 6C49 Disorders due to use of hallucinogens 6C4A Disorders due to use of nicotine 6C4B Disorders due to use of volatile inhalants 6C4C Disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA] 6C4D Disorders due to use of dissociative drugs including ketamine or phencyclidine (PCP) 6C4E Disorders due to use of other specified psychoactive substances, including medications 6C4F Disorders due to use of multiple specified psychoactive substances, including medications 6C4G Disorders due to use of unknown or unspecified psychoactive substances 6C4H Disorders due to use of non-psychoactive substances 6C4Y Other specified disorders due to substance use 6C4Z Disorders due to substance use, unspecified 6C40.0 Episode of harmful use of alcohol 6C40.1 Harmful pattern of use of alcohol 6C40.2 Alcohol dependence 6C40.3 Alcohol intoxication 6C40.4 Alcohol withdrawal 6C40.5 Alcohol-induced delirium 6C40.6 Alcohol-induced psychotic disorder 6C40.7 Certain specified alcohol-induced mental or behavioural disorders 6C40.Y Other specified disorders due to use of alcohol 6C40.Z Disorders due to use of alcohol, unspecified 6C41.0 Episode of harmful use of cannabis 6C41.1 Harmful pattern of use of cannabis 6C41.2 Cannabis dependence 6C41.3 Cannabis intoxication 6C41.4 Cannabis withdrawal 6C41.5 Cannabis-induced delirium 6C41.6 Cannabis-induced psychotic disorder 6C41.7 Certain specified cannabis-induced mental or behavioural disorders 6C41.Y Other specified disorders due to use of cannabis 6C41.Z Disorders due to use of cannabis, unspecified 6C42.0 Episode of harmful use of synthetic cannabinoids 6C42.1 Harmful pattern of use of synthetic cannabinoids 6C42.2 Synthetic cannabinoid dependence 6C42.3 Synthetic cannabinoid intoxication 6C42.4 Synthetic cannabinoid withdrawal 6C42.5 Synthetic cannabinoid-induced delirium 6C42.6 Synthetic cannabinoid-induced psychotic disorder 6C42.7 Certain specified synthetic cannabinoids-induced mental or behavioural disorders 6C42.Y Other specified disorders due to use of synthetic cannabinoids 6C42.Z Disorders due to use of synthetic cannabinoids, unspecified 6C43.0 Episode of harmful use of opioids 6C43.1 Harmful pattern of use of opioids 6C43.2 Opioid dependence 6C43.3 Opioid intoxication 6C43.4 Opioid withdrawal 6C43.5 Opioid-induced delirium 6C43.6 Opioid-induced psychotic disorder 6C43.7 Certain specified opioid-induced mental or behavioural disorders 6C43.Y Other specified disorders due to use of opioids 6C43.Z Disorders due to use of opioids, unspecified 6C44.0 Episode of harmful use of sedatives, hypnotics or anxiolytics 6C44.1 Harmful pattern of use of sedatives, hypnotics or anxiolytics 6C44.2 Sedative, hypnotic or anxiolytic dependence 6C44.3 Sedative, hypnotic or anxiolytic intoxication 6C44.4 Sedative, hypnotic or anxiolytic withdrawal 6C44.5 Sedative, hypnotic or anxiolytic-induced delirium 6C44.6 Sedative, hypnotic or anxiolytic-induced psychotic disorder 6C44.7 Certain specified sedatives, hypnotics or anxiolytic-induced mental or behavioural disorders 6C44.Y Other specified disorders due to use of sedatives, hypnotics or anxiolytics 6C44.Z Disorders due to use of sedatives, hypnotics or anxiolytics, unspecified 6C45.0 Episode of harmful use of cocaine 6C45.1 Harmful pattern of use of cocaine 6C45.2 Cocaine dependence 6C45.3 Cocaine intoxication 6C45.4 Cocaine withdrawal 6C45.5 Cocaine-induced delirium 6C45.6 Cocaine-induced psychotic disorder 6C45.7 Certain specified cocaine-induced mental or behavioural disorders 6C45.Y Other specified disorders due to use of cocaine 6C45.Z Disorders due to use of cocaine, unspecified 6C46.0 Episode of harmful use of stimulants including amphetamines, methamphetamine or methcathinone 6C46.1 Harmful pattern of use of stimulants including amphetamines, methamphetamine or methcathinone 6C46.2 Stimulant dependence including amphetamines, methamphetamine or methcathinone 6C46.3 Stimulant intoxication including amphetamines, methamphetamine or methcathinone 6C46.4 Stimulant withdrawal including amphetamines, methamphetamine or methcathinone 6C46.5 Stimulant-induced delirium including amphetamines, methamphetamine or methcathinone 6C46.6 Stimulant-induced psychotic disorder including amphetamines, methamphetamine or methcathinone 6C46.7 Certain specified stimulant-induced mental or behavioural disorders including amphetamines, methamphetamine or methcathinone 6C46.Y Other specified disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone 6C46.Z Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone, unspecified 6C47.0 Episode of harmful use of synthetic cathinones 6C47.1 Harmful pattern of use of synthetic cathinones 6C47.2 Synthetic cathinone dependence 6C47.3 Synthetic cathinone intoxication 6C47.4 Synthetic cathinone withdrawal 6C47.5 Synthetic cathinone-induced delirium 6C47.6 Synthetic cathinone-induced psychotic disorder 6C47.7 Certain specified synthetic cathinone-induced mental or behavioural disorders 6C47.Y Other specified disorders due to use of synthetic cathinones 6C47.Z Disorders due to use of synthetic cathinones, unspecified 6C48.0 Episode of harmful use of caffeine 6C48.1 Harmful pattern of use of caffeine 6C48.2 Caffeine intoxication 6C48.3 Caffeine withdrawal 6C48.4 Certain specified caffeine-induced mental or behavioural disorders 6C48.Y Other specified disorders due to use of caffeine 6C48.Z Disorders due to use of caffeine, unspecified 6C49.0 Episode of harmful use of hallucinogens 6C49.1 Harmful pattern of use of hallucinogens 6C49.2 Hallucinogen dependence 6C49.3 Hallucinogen intoxication 6C49.4 Hallucinogen-induced delirium 6C49.5 Hallucinogen-induced psychotic disorder 6C49.6 Certain specified hallucinogen-induced mental or behavioural disorders 6C49.Y Other specified disorders due to use of hallucinogens 6C49.Z Disorders due to use of hallucinogens, unspecified 6C4A.0 Episode of harmful use of nicotine 6C4A.1 Harmful pattern of use of nicotine 6C4A.2 Nicotine dependence 6C4A.3 Nicotine intoxication 6C4A.4 Nicotine withdrawal 6C4A.Y Other specified disorders due to use of nicotine 6C4A.Z Disorders due to use of nicotine, unspecified 6C4B.0 Episode of harmful use of volatile inhalants 6C4B.1 Harmful pattern of use of volatile inhalants 6C4B.2 Volatile inhalant dependence 6C4B.3 Volatile inhalant intoxication 6C4B.4 Volatile inhalant withdrawal 6C4B.5 Volatile inhalant-induced delirium 6C4B.6 Volatile inhalant-induced psychotic disorder 6C4B.7 Certain specified volatile inhalants-induced mental or behavioural disorders 6C4B.Y Other specified disorders due to use of volatile inhalants 6C4B.Z Disorders due to use of volatile inhalants, unspecified 6C4C.0 Episode of harmful use of MDMA or related drugs, including MDA 6C4C.1 Harmful pattern of use of MDMA or related drugs, including MDA 6C4C.2 MDMA or related drug dependence, including MDA 6C4C.3 MDMA or related drug intoxication, including MDA 6C4C.4 MDMA or related drug withdrawal, including MDA 6C4C.5 MDMA or related drug-induced delirium, including MDA 6C4C.6 MDMA or related drug-induced psychotic disorder, including MDA 6C4C.7 Certain specified MDMA or related drug-induced mental or behavioural disorders, including MDA 6C4C.Y Other specified disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA] 6C4C.Z Disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA], unspecified 6C4D.0 Episode of harmful use of dissociative drugs including ketamine or PCP 6C4D.1 Harmful pattern of use of dissociative drugs, including ketamine or PCP 6C4D.2 Dissociative drug dependence including ketamine or PCP 6C4D.3 Dissociative drug intoxication including Ketamine or PCP 6C4D.4 Dissociative drug-induced delirium including ketamine or PCP 6C4D.5 Dissociative drug-induced psychotic disorder including ketamine or PCP 6C4D.6 Certain specified dissociative drug-induced mental or behavioural disorders, including ketamine or phencyclidine (PCP) 6C4D.Y Other specified disorders due to use of dissociative drugs including ketamine or phencyclidine (PCP) 6C4D.Z Disorders due to use of dissociative drugs including ketamine or phencyclidine (PCP), unspecified 6C4E.0 Episode of harmful use of other specified psychoactive substance 6C4E.1 Harmful pattern of use of other specified psychoactive substance 6C4E.2 Other specified psychoactive substance dependence 6C4E.3 Other specified psychoactive substance intoxication 6C4E.4 Other specified psychoactive substance withdrawal 6C4E.5 Delirium induced by other specified psychoactive substance including medications 6C4E.6 Psychotic disorder induced by other specified psychoactive substance 6C4E.7 Certain other specified psychoactive substance-induced mental or behavioural disorders 6C4E.Y Other specified disorders due to use of other specified psychoactive substances, including medications 6C4E.Z Disorders due to use of other specified psychoactive substances, including medications, unspecified 6C4F.0 Episode of harmful use of multiple specified psychoactive substances 6C4F.1 Harmful pattern of use of multiple specified psychoactive substances 6C4F.2 Multiple specified psychoactive substances dependence 6C4F.3 Intoxication due to multiple specified psychoactive substances 6C4F.4 Multiple specified psychoactive substances withdrawal 6C4F.5 Delirium induced by multiple specified psychoactive substances including medications 6C4F.6 Psychotic disorder induced by multiple specified psychoactive substances 6C4F.7 Certain multiple specified psychoactive substances-induced mental or behavioural disorders 6C4F.Y Other specified disorders due to use of multiple specified psychoactive substances, including medications 6C4F.Z Disorders due to use of multiple specified psychoactive substances, including medications, unspecified 6C4G.0 Episode of harmful use of unknown or unspecified psychoactive substances 6C4G.1 Harmful pattern of use of unknown or unspecified psychoactive substance 6C4G.2 Unknown or unspecified psychoactive substance dependence 6C4G.3 Intoxication due to unknown or unspecified psychoactive substance 6C4G.4 Withdrawal due to unknown or unspecified psychoactive substance 6C4G.5 Delirium induced by unknown or unspecified psychoactive substance 6C4G.6 Psychotic disorder induced by unknown or unspecified psychoactive substance 6C4G.7 Certain unknown or unspecified psychoactive substance-induced mental or behavioural disorders 6C4G.Y Other specified disorders due to use of unknown or unspecified psychoactive substances 6C4G.Z Disorders due to use of unknown or unspecified psychoactive substances, unspecified 6C4H.0 Episode of harmful use of non-psychoactive substances 6C4H.1 Harmful pattern of use of non-psychoactive substances 6C4H.Y Other specified disorders due to use of non-psychoactive substances 6C4H.Z Disorders due to use of non-psychoactive substances, unspecified 6C40.10 Harmful pattern of use of alcohol, episodic 6C40.11 Harmful pattern of use of alcohol, continuous 6C40.1Z Harmful pattern of use of alcohol, unspecified 6C40.20 Alcohol dependence, current use, continuous 6C40.21 Alcohol dependence, current use, episodic 6C40.22 Alcohol dependence, early full remission 6C40.23 Alcohol dependence, sustained partial remission 6C40.24 Alcohol dependence, sustained full remission 6C40.2Z Alcohol dependence, unspecified 6C40.40 Alcohol withdrawal, uncomplicated 6C40.41 Alcohol withdrawal with perceptual disturbances 6C40.42 Alcohol withdrawal with seizures 6C40.43 Alcohol withdrawal with perceptual disturbances and seizures 6C40.4Z Alcohol withdrawal, unspecified 6C40.60 Alcohol-induced psychotic disorder with hallucinations 6C40.61 Alcohol-induced psychotic disorder with delusions 6C40.62 Alcohol-induced psychotic disorder with mixed psychotic symptoms 6C40.6Z Alcohol-induced psychotic disorder, unspecified 6C40.70 Alcohol-induced mood disorder 6C40.71 Alcohol-induced anxiety disorder 6C41.10 Harmful pattern of use of cannabis, episodic 6C41.11 Harmful pattern of use of cannabis, continuous 6C41.1Z Harmful pattern of use of cannabis, unspecified 6C41.20 Cannabis dependence, current use 6C41.21 Cannabis dependence, early full remission 6C41.22 Cannabis dependence, sustained partial remission 6C41.23 Cannabis dependence, sustained full remission 6C41.2Z Cannabis dependence, unspecified 6C41.70 Cannabis-induced mood disorder 6C41.71 Cannabis-induced anxiety disorder 6C42.10 Harmful pattern of use of synthetic cannabinoids, episodic 6C42.11 Harmful pattern of use of synthetic cannabinoids, continuous 6C42.1Y Other specified harmful pattern of use of synthetic cannabinoids 6C42.1Z Harmful pattern of use of synthetic cannabinoids, unspecified 6C42.20 Synthetic cannabinoid dependence, current use 6C42.21 Synthetic cannabinoid dependence, early full remission 6C42.22 Synthetic cannabinoid dependence, sustained partial remission 6C42.23 Synthetic cannabinoid dependence, sustained full remission 6C42.2Y Other specified synthetic cannabinoid dependence 6C42.2Z Synthetic cannabinoid dependence, unspecified 6C42.70 Synthetic cannabinoid-induced mood disorder 6C42.71 Synthetic cannabinoid-induced anxiety disorder 6C43.10 Harmful pattern of use of opioids, episodic 6C43.11 Harmful pattern of use of opioids, continuous 6C43.1Z Harmful pattern of use of opioids, unspecified 6C43.20 Opioid dependence, current use 6C43.21 Opioid dependence, early full remission 6C43.22 Opioid dependence, sustained partial remission 6C43.23 Opioid dependence, sustained full remission 6C43.2Z Opioid dependence, unspecified 6C43.70 Opioid-induced mood disorder 6C43.71 Opioid-induced anxiety disorder 6C44.10 Harmful pattern of use of sedatives, hypnotics or anxiolytics, episodic 6C44.11 Harmful pattern of use of sedatives, hypnotics or anxiolytics, continuous 6C44.1Z Harmful pattern of use of sedatives, hypnotics or anxiolytics, unspecified 6C44.20 Sedative, hypnotic or anxiolytic dependence, current use 6C44.21 Sedative, hypnotic or anxiolytic dependence, early full remission 6C44.22 Sedative, hypnotic or anxiolytic dependence, sustained partial remission 6C44.23 Sedative, hypnotic or anxiolytic dependence, sustained full remission 6C44.2Z Sedative, hypnotic or anxiolytic dependence, unspecified 6C44.40 Sedative, hypnotic or anxiolytic withdrawal, uncomplicated 6C44.41 Sedative, hypnotic or anxiolytic withdrawal, with perceptual disturbances 6C44.42 Sedative, hypnotic or anxiolytic withdrawal, with seizures 6C44.43 Sedative, hypnotic or anxiolytic withdrawal, with perceptual disturbances and seizures 6C44.4Z Sedative, hypnotic or anxiolytic withdrawal, unspecified 6C44.70 Sedative, hypnotic or anxiolytic-induced mood disorder 6C44.71 Sedative, hypnotic or anxiolytic-induced anxiety disorder 6C45.10 Harmful pattern of use of cocaine, episodic 6C45.11 Harmful pattern of use of cocaine, continuous 6C45.1Z Harmful pattern of use of cocaine, unspecified 6C45.20 Cocaine dependence, current use 6C45.21 Cocaine dependence, early full remission 6C45.22 Cocaine dependence, sustained partial remission 6C45.23 Cocaine dependence, sustained full remission 6C45.2Z Cocaine dependence, unspecified 6C45.60 Cocaine-induced psychotic disorder with hallucinations 6C45.61 Cocaine-induced psychotic disorder with delusions 6C45.62 Cocaine-induced psychotic disorder with mixed psychotic symptoms 6C45.6Z Cocaine-induced psychotic disorder, unspecified 6C45.70 Cocaine-induced mood disorder 6C45.71 Cocaine-induced anxiety disorder 6C45.72 Cocaine-induced obsessive-compulsive or related disorder 6C45.73 Cocaine-induced impulse control disorder 6C46.10 Harmful pattern of use of stimulants including amphetamines, methamphetamine or methcathinone, episodic 6C46.11 Harmful pattern of use of stimulants including amphetamines, methamphetamine or methcathinone, continuous 6C46.1Z Harmful pattern of use of stimulants including amphetamines, methamphetamine and methcathinone, unspecified 6C46.20 Stimulant dependence including amphetamines, methamphetamine or methcathinone, current use 6C46.21 Stimulant dependence including amphetamines, methamphetamine or methcathinone, early full remission 6C46.22 Stimulant dependence including amphetamines, methamphetamine or methcathinone, sustained partial remission 6C46.23 Stimulant dependence including amphetamines, methamphetamine or methcathinone, sustained full remission 6C46.2Z Stimulant dependence including amphetamines, methamphetamine or methcathinone, unspecified 6C46.60 Stimulant-induced psychotic disorder including amphetamines, methamphetamine or methcathinone with hallucinations 6C46.61 Stimulant-induced psychotic disorder including amphetamines, methamphetamine or methcathinone with delusions 6C46.62 Stimulant-induced psychotic disorder including amphetamines but excluding caffeine or cocaine with mixed psychotic symptoms 6C46.6Z Stimulant-induced psychotic disorder including amphetamines, methamphetamine or methcathinone, unspecified 6C46.70 Stimulant-induced mood disorder including amphetamines, methamphetamine or methcathinone 6C46.71 Stimulant-induced anxiety disorder including amphetamines, methamphetamine or methcathinone 6C46.72 Stimulant-induced obsessive-compulsive or related disorder including amphetamines, methamphetamine or methcathinone 6C46.73 Stimulant-induced impulse control disorder including amphetamines, methamphetamine or methcathinone 6C47.10 Harmful pattern of use of synthetic cathinones, episodic 6C47.11 Harmful use of synthetic cathinones, continuous 6C47.1Y Other specified harmful pattern of use of synthetic cathinones 6C47.1Z Harmful pattern of use of synthetic cathinones, unspecified 6C47.20 Synthetic cathinone dependence, current use 6C47.21 Synthetic cathinone dependence, early full remission 6C47.22 Synthetic cathinone dependence, sustained partial remission 6C47.23 Synthetic cathinone dependence, sustained full remission 6C47.2Y Other specified synthetic cathinone dependence 6C47.2Z Synthetic cathinone dependence, unspecified 6C47.60 Synthetic cathinone-induced psychotic disorder with hallucinations 6C47.61 Synthetic cathinone-induced psychotic disorder with delusions 6C47.62 Synthetic cathinone-induced psychotic disorder with mixed psychotic symptoms 6C47.6Z Synthetic cathinone-induced psychotic disorder, unspecified 6C47.70 Synthetic cathinone-induced mood disorder 6C47.71 Synthetic cathinone-induced anxiety disorder 6C47.72 Synthetic cathinone-induced obsessive-compulsive or related syndrome 6C47.73 Synthetic cathinone-induced impulse control disorder 6C48.10 Harmful pattern of use of caffeine, episodic 6C48.11 Harmful pattern of use of caffeine, continuous 6C48.1Z Harmful pattern of use of caffeine, unspecified 6C48.40 Caffeine-induced anxiety disorder 6C49.10 Harmful pattern of use of hallucinogens, episodic 6C49.11 Harmful pattern of use of hallucinogens, continuous 6C49.1Z Harmful pattern of use of hallucinogens, unspecified 6C49.20 Hallucinogen dependence, current use 6C49.21 Hallucinogen dependence, early full remission 6C49.22 Hallucinogen dependence, sustained partial remission 6C49.23 Hallucinogen dependence, sustained full remission 6C49.2Z Hallucinogen dependence, unspecified 6C49.60 Hallucinogen-induced mood disorder 6C49.61 Hallucinogen-induced anxiety disorder 6C4A.10 Harmful pattern of use of nicotine, episodic 6C4A.11 Harmful pattern of use of nicotine, continuous 6C4A.1Z Harmful pattern of use of nicotine, unspecified 6C4A.20 Nicotine dependence, current use 6C4A.21 Nicotine dependence, early full remission 6C4A.22 Nicotine dependence, sustained partial remission 6C4A.23 Nicotine dependence, sustained full remission 6C4A.2Z Nicotine dependence, unspecified 6C4B.10 Harmful pattern of use of volatile inhalants, episodic 6C4B.11 Harmful pattern of use of volatile inhalants, continuous 6C4B.1Z Harmful pattern of use of volatile inhalants, unspecified 6C4B.20 Volatile inhalant dependence, current use 6C4B.21 Volatile inhalant dependence, early full remission 6C4B.22 Volatile inhalant dependence, sustained partial remission 6C4B.23 Volatile inhalant dependence, sustained full remission 6C4B.2Z Volatile inhalant dependence, unspecified 6C4B.70 Volatile inhalant-induced mood disorder 6C4B.71 Volatile inhalant-induced anxiety disorder 6C4C.10 Harmful use of MDMA or related drugs, including MDA, episodic 6C4C.11 Harmful use of MDMA or related drugs, including MDA, continuous 6C4C.1Z Harmful pattern of use of MDMA or related drugs, including MDA, unspecified 6C4C.20 MDMA or related drug dependence, including MDA, current use 6C4C.21 MDMA or related drug dependence, including MDA, early full remission 6C4C.22 MDMA or related drug dependence, including MDA, sustained partial remission 6C4C.23 MDMA or related drug dependence, including MDA, sustained full remission 6C4C.2Z MDMA or related drug dependence, including MDA, unspecified 6C4C.70 MDMA or related drug-induced mood disorder, including MDA 6C4C.71 MDMA or related drug-induced anxiety disorder 6C4D.10 Harmful pattern of use of dissociative drugs including ketamine or PCP, episodic 6C4D.11 Harmful pattern of use of dissociative drugs including ketamine or PCP, continuous 6C4D.1Z Harmful pattern of use of dissociative drugs, including ketamine or PCP, unspecified 6C4D.20 Dissociative drug dependence including Ketamine or PCP, current use 6C4D.21 Dissociative drug dependence including ketamine or PCP, early full remission 6C4D.22 Dissociative drug dependence including Ketamine or PCP, sustained partial remission 6C4D.23 Dissociative drug dependence including Ketamine or PCP, sustained full remission 6C4D.2Z Dissociative drug dependence including ketamine or PCP, unspecified 6C4D.60 Dissociative drug-induced mood disorder including ketamine or phencyclidine (PCP) 6C4D.61 Dissociative drug-induced anxiety disorder including ketamine or PCP 6C4E.10 Harmful pattern of use of other specified psychoactive substance, episodic 6C4E.11 Harmful pattern of use of other specified psychoactive substance, continuous 6C4E.1Z Harmful pattern of use of other specified psychoactive substance, unspecified 6C4E.20 Other specified psychoactive substance dependence, current use 6C4E.21 Other specified psychoactive substance dependence, early full remission 6C4E.22 Other specified psychoactive substance dependence, sustained partial remission 6C4E.23 Other specified psychoactive substance dependence, sustained full remission 6C4E.2Z Other specified psychoactive substance dependence, unspecified 6C4E.40 Other specified psychoactive substance withdrawal, uncomplicated 6C4E.41 Other specified psychoactive substance withdrawal, with perceptual disturbances 6C4E.42 Other specified psychoactive substance withdrawal, with seizures 6C4E.43 Other specified psychoactive substance withdrawal, with perceptual disturbances and seizures 6C4E.4Z Other specified psychoactive substance withdrawal, unspecified 6C4E.70 Mood disorder induced by other specified psychoactive substance 6C4E.71 Anxiety disorder induced by other specified psychoactive substance 6C4E.72 Obsessive-compulsive or related disorder induced by other specified psychoactive substance 6C4E.73 Impulse control disorder induced by other specified psychoactive substance 6C4F.10 Harmful pattern of use of multiple specified psychoactive substances, episodic 6C4F.11 Harmful pattern of use of multiple specified psychoactive substances, continuous 6C4F.1Z Harmful pattern of use of multiple specified psychoactive substances, unspecified 6C4F.20 Multiple specified psychoactive substances dependence, current use 6C4F.21 Multiple specified psychoactive substances dependence, early full remission 6C4F.22 Multiple specified psychoactive substances dependence, sustained partial remission 6C4F.23 Multiple specified psychoactive substances dependence, sustained full remission 6C4F.2Z Multiple specified psychoactive substances dependence, unspecified 6C4F.40 Multiple specified psychoactive substances withdrawal, uncomplicated 6C4F.41 Multiple specified psychoactive substances withdrawal, with perceptual disturbances 6C4F.42 Multiple specified psychoactive substances withdrawal, with seizures 6C4F.43 Multiple specified psychoactive substances withdrawal, with perceptual disturbances and seizures 6C4F.4Y Other specified multiple specified psychoactive substances withdrawal 6C4F.4Z Multiple specified psychoactive substances withdrawal, unspecified 6C4F.70 Mood disorder induced by multiple specified psychoactive substances 6C4F.71 Anxiety disorder induced by multiple specified psychoactive substances 6C4F.72 Obsessive-compulsive or related disorder induced by multiple specified psychoactive substances 6C4F.73 Impulse control disorder induced by multiple specified psychoactive substances 6C4G.10 Harmful pattern of use of unknown or unspecified psychoactive substance, episodic 6C4G.11 Harmful pattern of use of unknown or unspecified psychoactive substance, continuous 6C4G.1Z Harmful pattern of use of unknown or unspecified psychoactive substance, unspecified 6C4G.20 Unknown or unspecified psychoactive substance dependence, current use 6C4G.21 Unknown or unspecified psychoactive substance dependence, early full remission 6C4G.22 Unknown or unspecified psychoactive substance dependence, sustained partial remission 6C4G.23 Unknown or unspecified psychoactive substance dependence, sustained full remission 6C4G.2Z Unknown or unspecified psychoactive substance dependence, substance and state of remission unspecified 6C4G.40 Withdrawal due to unknown or unspecified psychoactive substance, uncomplicated 6C4G.41 Withdrawal due to unknown or unspecified psychoactive substance, with perceptual disturbances 6C4G.42 Withdrawal due to unknown or unspecified psychoactive substance, with seizures 6C4G.43 Withdrawal due to unknown or unspecified psychoactive, with perceptual disturbances and seizures 6C4G.4Z Withdrawal due to unknown or unspecified psychoactive substance, unspecified 6C4G.70 Mood disorder induced by unknown or unspecified psychoactive substance 6C4G.71 Anxiety disorder induced by unknown or unspecified psychoactive substance 6C4G.72 Obsessive-compulsive or related disorder induced by unknown or unspecified psychoactive substance 6C4G.73 Impulse control disorder induced by unknown or unspecified psychoactive substance 6C4H.10 Harmful pattern of use of non-psychoactive substances, episodic 6C4H.11 Harmful pattern of use of non-psychoactive substances, continuous 6C4H.1Z Harmful pattern of use of non-psychoactive substances, unspecified 8A00.0 Parkinson disease 8A00.00 Sporadic Parkinson disease 8A00.01 Familial Parkinson disease 8A00.0Y Other specified Parkinson disease 8A00.0Z Parkinson disease, unspecified 8A01.10 Huntington disease 8A20 Alzheimer disease 8A22 Lewy body disease 8A23 Frontotemporal lobar degeneration 8A40 Multiple sclerosis 8A40.0 Relapsing-remitting multiple sclerosis 8A40.1 Primary progressive multiple sclerosis 8A40.2 Secondary progressive multiple sclerosis 8A40.Y Other specified multiple sclerosis 8A40.Z Multiple sclerosis, unspecified 8B20 Stroke not known if ischaemic or haemorrhagic 8B21 Cerebrovascular disease with no acute cerebral symptom 8B22 Certain specified cerebrovascular diseases 8B23 Cerebrovascular abnormalities 8B24 Hypoxic-ischaemic encephalopathy 8B25 Late effects of cerebrovascular disease 8B26 Vascular syndromes of brain in cerebrovascular diseases 8B2Z Cerebrovascular diseases, unspecified 8B00 Intracerebral haemorrhage 8B01 Subarachnoid haemorrhage 8B02 Nontraumatic subdural haemorrhage 8B03 Nontraumatic epidural haemorrhage 8B0Z Intracranial haemorrhage, unspecified 8B10 Transient ischaemic attack 8B11 Cerebral ischaemic stroke 8B1Y Other specified cerebral ischaemia 8B1Z Cerebral ischaemia, unspecified 8B21.0 Silent cerebral infarct 8B21.1 Silent cerebral microbleed 8B21.Y Other specified cerebrovascular disease with no acute cerebral symptom 8B21.Z Cerebrovascular disease with no acute cerebral symptom, unspecified 8B22.0 Dissection of cerebral arteries 8B22.1 Cerebral venous thrombosis 8B22.2 Cerebral vasoconstriction syndromes 8B22.3 Isolated cerebral amyloid angiopathy 8B22.4 Intracranial vascular malformation 8B22.5 Cerebral aneurysm, nonruptured 8B22.6 Familial cerebral saccular aneurysm 8B22.7 Cerebral arteritis, not elsewhere classified 8B22.8 Hypertensive encephalopathy 8B22.9 Migraine-induced stroke 8B22.A Subclavian steal syndrome 8B22.B Moyamoya syndrome 8B22.C Hereditary cerebrovascular diseases 8B22.Y Other specified cerebrovascular disease 8B24.0 Anoxic-ischaemic encephalopathy 8B24.Y Other specified hypoxic-ischaemic encephalopathy 8B24.Z Hypoxic-ischaemic encephalopathy, unspecified 8B25.0 Late effects of cerebral ischemic stroke 8B25.1 Late effects of intracerebral haemorrhage 8B25.2 Late effects of subarachnoid haemorrhage 8B25.3 Late effects of other nontraumatic intracranial haemorrhage 8B25.4 Late effects of stroke not known if ischaemic or haemorrhagic 8B25.Y Late effects of other specified cerebrovascular disease 8B25.Z Late effects of cerebrovascular disease, unspecified 8B26.0 Brainstem stroke syndrome 8B26.1 Cerebellar stroke syndrome 8B26.2 Middle cerebral artery syndrome 8B26.3 Anterior cerebral artery syndrome 8B26.4 Posterior cerebral artery syndrome 8B26.5 Lacunar syndromes 8B26.Y Other specified vascular syndromes of brain in cerebrovascular diseases 8B26.Z Vascular syndromes of brain in cerebrovascular diseases, unspecified 8B00.0 Deep hemispheric haemorrhage 8B00.1 Lobar haemorrhage 8B00.2 Brainstem haemorrhage 8B00.3 Cerebellar haemorrhage 8B00.4 Intraventricular haemorrhage without parenchymal haemorrhage 8B00.5 Haemorrhage of multiple sites 8B00.Z Intracerebral haemorrhage, site unspecified 8B01.0 Aneurysmal subarachnoid haemorrhage 8B01.1 Non-aneurysmal subarachnoid haemorrhage 8B01.2 Subarachnoid haemorrhage not known if aneurysmal or non-aneurysmal 8B10.0 Amaurosis fugax 8B10.Y Other specified transient ischaemic attack 8B10.Z Transient ischaemic attack, unspecified 8B11.0 Cerebral ischaemic stroke due to extracranial large artery atherosclerosis 8B11.1 Cerebral ischaemic stroke due to intracranial large artery atherosclerosis 8B11.2 Cerebral ischaemic stroke due to embolic occlusion 8B11.3 Cerebral ischaemic stroke due to small artery occlusion 8B11.4 Cerebral ischaemic stroke due to other known cause 8B11.5 Cerebral ischaemic stroke of unknown cause 8B22.40 Arteriovenous malformation of cerebral vessels 8B22.41 Cerebral cavernous malformation 8B22.42 Dural arteriovenous fistula 8B22.43 Carotid cavernous fistula 8B22.4Y Other specified intracranial vascular malformation 8B22.4Z Intracranial vascular malformation, unspecified 8B22.70 Primary cerebral arteritis 8B22.7Y Other specified cerebral arteritis, not elsewhere classified 8B22.7Z Cerebral arteritis, not elsewhere classified, unspecified 8B22.C0 CADASIL - [cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy] syndrome 8B22.C1 CARASIL - [cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy] syndrome 8B22.CY Other specified hereditary cerebrovascular diseases 8B22.CZ Hereditary cerebrovascular diseases, unspecified 8B26.50 Pure motor lacunar syndrome 8B26.51 Pure sensory lacunar syndrome 8B26.5Y Other specified lacunar syndromes 8B26.5Z Lacunar syndromes, unspecified 8B11.20 Cerebral ischaemic stroke due to cardiac embolism 8B11.21 Cerebral ischaemic stroke due to aortic arch embolism 8B11.22 Cerebral ischaemic stroke due to paradoxical embolism 8B11.2Y Cerebral ischaemic stroke due to other specified embolic occlusion 8B11.2Z Cerebral ischaemic stroke due to embolic occlusion, unspecified 8B11.40 Cerebral ischaemic stroke due to global hypoperfusion with watershed infarct 8B11.41 Cerebral ischaemic stroke due to other non-atherosclerotic arteriopathy 8B11.42 Cerebral ischaemic stroke due to hypercoagulable state 8B11.43 Cerebral ischaemic stroke in association with subarachnoid haemorrhage 8B11.44 Cerebral ischemic stroke from dissection 8B11.50 Cerebral ischaemic stroke due to unspecified occlusion or stenosis of extracranial large artery 8B11.51 Cerebral ischaemic stroke due to unspecified occlusion or stenosis of intracranial large artery 8B11.5Z Cerebral ischaemic stroke, unspecified 8D64.04 Normal-pressure hydrocephalus 8E00 Sporadic Creutzfeldt-Jakob Disease 8E01 Acquired prion disease 8E02 Genetic prion diseases 8E03 Variably protease sensitive prionopathy 8E0Y Other specified human prion diseases 8E0Z Human prion diseases, unspecified 8E01.0 Iatrogenically acquired Creutzfeldt-Jakob Disease 8E01.1 Kuru 8E01.2 Variant Creutzfeldt-Jakob Disease 8E01.3 Other acquired Creutzfeldt-Jakob Disease 8E01.Z Acquired prion disease, unspecified 8E02.0 Genetic Creutzfeldt-Jakob disease 8E02.1 Gerstmann-Straussler-Scheinker syndrome 8E02.2 Fatal familial insomnia 8E02.Y Other specified genetic prion diseases 8E02.Z Genetic prion diseases, unspecified LD40.0 Complete trisomy 21 NA07 Intracranial injury NA07.0 Concussion NA07.1 Traumatic intracerebral haemorrhage NA07.2 Traumatic cerebral oedema NA07.3 Diffuse brain injury NA07.4 Focal brain injury NA07.5 Traumatic epidural haemorrhage NA07.6 Traumatic subdural haemorrhage NA07.7 Traumatic subarachnoid haemorrhage NA07.8 Traumatic haemorrhage in brain tissue NA07.Y Other specified intracranial injury NA07.Z Intracranial injury, unspecified NA07.00 Concussion with incomplete loss of consciousness with amnesia NA07.01 Concussion with incomplete loss of consciousness without amnesia NA07.02 Concussion with loss of consciousness, short duration of less than 30 minutes NA07.03 Concussion with loss of consciousness, short duration of 30 minutes to less than one hour NA07.04 Concussion with loss of consciousness, short duration of one hour to less than 6 hours NA07.05 Concussion with loss of consciousness, intermediate duration of 6 hours to less than 24 hours NA07.06 Concussion with loss of consciousness, persisting longer than 24 hours or until discharge or latest assessment NA07.07 Concussion with loss of consciousness, persisting until death NA07.08 Concussion with loss of consciousness, duration unspecified or unknown due to effects of therapy NA07.09 Concussion with loss of consciousness, duration unspecified or unknown due to lack of information NA07.0Y Other specified concussion NA07.0Z Concussion, unspecified NA07.20 Diffuse traumatic cerebral oedema NA07.21 Focal traumatic cerebral oedema NA07.2Y Other specified traumatic cerebral oedema NA07.2Z Traumatic cerebral oedema, unspecified NA07.30 Diffuse injury of cerebrum NA07.31 Diffuse injury of cerebellum NA07.32 Diffuse injury of brainstem NA07.33 Diffuse injury of multiple parts of brain NA07.3Y Other specified diffuse brain injury NA07.3Z Unspecified diffuse traumatic brain injury NA07.40 Focal non-haemorrhagic contusion of cerebrum NA07.41 Focal haemorrhagic contusion of cerebrum NA07.42 Focal laceration of cerebrum NA07.43 Multiple focal injuries of cerebrum NA07.44 Focal non-haemorrhagic contusion of cerebellum NA07.45 Focal haematoma or haemorrhage of cerebellum NA07.46 Focal laceration of cerebellum NA07.47 Multiple focal injuries of cerebellum NA07.48 Focal non-haemorrhagic contusion of brainstem NA07.49 Focal haematoma or haemorrhage of brainstem NA07.4A Contusion of temporal lobe NA07.4B Focal laceration of brainstem NA07.4C Focal brain contusion NA07.4D Focal brain laceration NA07.4E Contusion of parietal lobe NA07.4F Contusion of occipital lobe NA07.4Z Unspecified focal traumatic brain injury NA07.60 Acute traumatic subdural haemorrhage NA07.61 Chronic traumatic subdural haemorrhage NA07.6Z Traumatic subdural haemorrhage, unspecified whether acute or chronic NA07.80 Traumatic haemorrhage in cerebrum white matter NA07.81 Traumatic haemorrhage in thalamus or basal ganglia NA07.82 Traumatic haemorrhage in cerebellum NA07.83 Traumatic haemorrhage in brainstem without specification whether primary or secondary NA07.84 Traumatic haemorrhage in brainstem, primary NA07.85 Traumatic haemorrhage in brainstem, secondary NA07.86 Multiple traumatic haemorrhages NA07.8Y Other specified traumatic haemorrhage in brain tissue NA07.8Z Traumatic haemorrhage in brain tissue, unspecified NE61 Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified
synonyms Mild neurocognitive disorder minor neurocognitive disorder Postconcussional syndrome concussion syndrome nonpsychotic post-traumatic brain syndrome post-concussion syndrome post-concussional syndrome post-contusional encephalopathy post-contusional syndrome post-traumatic brain syndrome post-traumatic dementia post-traumatic organic brain syndrome postconcussion syndrome postconcussional disorder postcontusional syndrome punch drunk status postcommotio cerebri Postcontusional encephalopathy Mild cognitive impairment Mild lack of memory following organic brain damage Mild memory disorder following organic brain damage Mild memory disturbance following organic brain damage Mild memory loss following organic brain damage
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Aimee - AI-powered coding assistant
Would you like Aimee - AI to help you with this?